Results of All-Trans Retinoic Acid Treatment in Acute Promyelocytic Leukemia (European Experience)

[1]  P. Fenaux,et al.  Retinoic Acid Syndrome , 1998, Drug safety.

[2]  H. Dombret,et al.  All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. , 1995, Blood.

[3]  M. Fey,et al.  Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter] , 1994 .

[4]  M. Fey,et al.  Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group. , 1994, Blood.

[5]  N. Tsukada,et al.  Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. , 1994, Leukemia.

[6]  N. Stuurman,et al.  The t(15;17) translocation alters a nuclear body in a retinoic acid‐reversible fashion. , 1994, The EMBO journal.

[7]  P. Fenaux,et al.  Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group , 1993 .

[8]  H. de Thé,et al.  PML protein expression in hematopoietic and acute promyelocytic leukemia cells. , 1993, Blood.

[9]  R. Warrell,et al.  Acute promyelocytic leukemia. , 1993, The New England journal of medicine.

[10]  J. Lacerda,et al.  Multiple thrombosis in acute promyelocytic leukaemia after tretinoin , 1993, The Lancet.

[11]  H. Dombret,et al.  All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. , 1992, Blood.

[12]  R. Warrell,et al.  The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia , 1992, Annals of Internal Medicine.

[13]  C. Chomienne,et al.  Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. , 1992, Cancer research.

[14]  A. Dejean,et al.  A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. , 1992, Blood.

[15]  R. Warrell,et al.  Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. , 1992, Cancer research.

[16]  H. Dombret,et al.  Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid , 1990, The Lancet.

[17]  R Berger,et al.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.

[18]  P. Fenaux,et al.  All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. , 1990, Blood.

[19]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[20]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[21]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[22]  M. Boiron,et al.  Acute promyelocytic leukemia: results of treatment by daunorubicin. , 1973, Blood.

[23]  H. Dombret,et al.  Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. , 1993, Leukemia.

[24]  H. Dombret,et al.  All trans retinoic acid treatment for patients with acute promyelocytic leukemia. , 1992, Leukemia.

[25]  M. Flint.  Letter: Pathogenesis of osteoarthrosis. , 1974, Lancet.